Gastrointestinal/liver-targeted TLR7 agonist for treatment of colorectal and liver cancers

被引：1
|
作者：
Miller, Andrew T. [1 ]
Rodrigo, Evelyn [1 ]
Corpuz, Manny [1 ]
Plouffe, David [1 ]
Wu, Tom Y-H [1 ]
机构：
[1] Apros Therapeut, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
684
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response
    Wan, Dandan
    Que, Haiying
    Chen, Li
    Lan, Tianxia
    Hong, Weiqi
    He, Cai
    Yang, Jingyun
    Wei, Yuquan
    Wei, Xiawei
    NANO LETTERS, 2021, 21 (19) : 7960 - 7969
  • [32] The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity
    Agier, Justyna
    Brzezinska-Blaszczyk, Ewa
    Witczak, Piotr
    Kozlowska, Elzbieta
    Zelechowska, Paulina
    CELLULAR IMMUNOLOGY, 2021, 359
  • [33] Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes
    Wan, Dandan
    Bai, Ziyi
    Zhang, Yu
    Chen, Li
    Que, Haiying
    Lan, Tianxia
    Hong, Weiqi
    Huang, Jiayu
    He, Cai
    Wei, Yuquan
    Pu, Qiang
    Wei, Xiawei
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (10) : 4577 - 4590
  • [34] Role of TLR7 in development of alcoholic fatty liver disease: a new target for prevention of alcoholic fatty liver disease
    Matsumoto, Hiroshi
    Yang, Chipin
    Sugimoto, Kana
    FASEB JOURNAL, 2016, 30
  • [35] Mucus penetrating and liver-targeted celastrol nanoparticles as potent oral nanomedicine for treatment of MAFLD
    Xu, C.
    Xu, D.
    Qiu, N.
    Xu, X.
    TRANSPLANTATION, 2023, 107 (09) : 70 - 71
  • [36] Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
    Korolowizc, Kyle E.
    Li, Bin
    Huang, Xu
    Yon, Changsuek
    Rodrigo, Evelyn
    Corpuz, Manny
    Plouffe, David M.
    Kallakury, Bhaskar, V
    Suresh, Manasa
    Wu, Tom Y-H
    Miller, Andrew T.
    Menne, Stephan
    HEPATOLOGY COMMUNICATIONS, 2019, 3 (10) : 1296 - 1310
  • [37] Preclinical analysis of liver-targeted, mild mitochondrial protonophores for treatment of non-alcoholic fatty liver disease and steatohepatitis
    Hansson, Magnus
    Moss, Steven
    Piel, Sarah
    Chamkha, Imen
    Gronberg, Alvar
    Gregory, Matthew
    Elmer, Eskil
    HEPATOLOGY, 2017, 66 : 1050A - 1050A
  • [38] Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
    Ningning Gao
    Jingjing Zhong
    Xiaodong Wang
    Zhenchao Jin
    Wang Li
    Yu Liu
    Yuwen Diao
    Zhulin Wang
    Wenqi Jiang
    Guangyi Jin
    Scientific Reports, 6
  • [39] Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
    Gao, Ningning
    Zhong, Jingjing
    Wang, Xiaodong
    Jin, Zhenchao
    Li, Wang
    Liu, Yu
    Diao, Yuwen
    Wang, Zhulin
    Jiang, Wenqi
    Jin, Guangyi
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist
    Johansen, Pia T.
    Zucker, Daniel
    Parhamifar, Ladan
    Pourhassan, Houman
    Madsen, Ditte Villum
    Henriksen, Jonas R.
    Gad, Monika
    Barberis, Alcide
    Maj, Roberto
    Andresen, Thomas L.
    Jensent, Simon S.
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (07) : 1045 - 1058
12345